Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Companies waver in efforts to target transforming growth factor beta in cancer.

× No keyword cloud information.

13 in total

1. Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors.

Authors: Yiran Zheng; Li Tang; Llian Mabardi; Sudha Kumari; Darrell J Irvine
Journal: ACS Nano Date: 2017-03-01 Impact factor: 15.881

Review 2. Potential approaches to reverse or repair renal fibrosis.

Authors: Desiree Tampe; Michael Zeisberg
Journal: Nat Rev Nephrol Date: 2014-02-11 Impact factor: 28.314

3. Targeting small molecule drugs to T cells with antibody-directed cell-penetrating gold nanoparticles.

Authors: Yu-Sang Sabrina Yang; Kelly D Moynihan; Ahmet Bekdemir; Tanmay M Dichwalkar; Michelle M Noh; Nicki Watson; Mariane Melo; Jessica Ingram; Heikyung Suh; Hidde Ploegh; Francesco R Stellacci; Darrell J Irvine
Journal: Biomater Sci Date: 2018-12-18 Impact factor: 6.843

4. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma.

Authors: Yanxia Zhao; Jinghong Cao; Alexander Melamed; Michael Worley; Allison Gockley; Dennis Jones; Hadi T Nia; Yanling Zhang; Triantafyllos Stylianopoulos; Ashwin S Kumar; Fotios Mpekris; Meenal Datta; Yao Sun; Limeng Wu; Xing Gao; Oladapo Yeku; Marcela G Del Carmen; David R Spriggs; Rakesh K Jain; Lei Xu
Journal: Proc Natl Acad Sci U S A Date: 2019-01-18 Impact factor: 11.205

Review 5. Kidney Fibrosis: Origins and Interventions.

Authors: Thomas Vanhove; Roel Goldschmeding; Dirk Kuypers
Journal: Transplantation Date: 2017-04 Impact factor: 4.939

6. Identification of retinoic acid in a high content screen for agents that overcome the anti-myogenic effect of TGF-beta-1.

Authors: Chateen Krueger; F Michael Hoffmann
Journal: PLoS One Date: 2010-11-30 Impact factor: 3.240

7. Potentiating tumor immunity using aptamer-targeted RNAi to render CD8⁺ T cells resistant to TGFβ inhibition.

Authors: Yvonne Puplampu-Dove; Tal Gefen; Anugraha Rajagopalan; Darija Muheramagic; Brett Schrand; Eli Gilboa
Journal: Oncoimmunology Date: 2018-02-15 Impact factor: 8.110

8. Inhibition of radiation-induced skin fibrosis with imatinib.

Authors: Jason A Horton; Eun Joo Chung; Kathryn E Hudak; Anastasia Sowers; Angela Thetford; Ayla O White; James B Mitchell; Deborah E Citrin
Journal: Int J Radiat Biol Date: 2012-11-19 Impact factor: 2.694

9. Simultaneous Inhibition of LSD1 and TGFβ Enables Eradication of Poorly Immunogenic Tumors with Anti-PD-1 Treatment.

Authors: Wanqiang Sheng; Yi Liu; Damayanti Chakraborty; Brian Debo; Yang Shi
Journal: Cancer Discov Date: 2021-03-09 Impact factor: 39.397

Review 10. Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway.

Authors: Stephan Herbertz; J Scott Sawyer; Anja J Stauber; Ivelina Gueorguieva; Kyla E Driscoll; Shawn T Estrem; Ann L Cleverly; Durisala Desaiah; Susan C Guba; Karim A Benhadji; Christopher A Slapak; Michael M Lahn
Journal: Drug Des Devel Ther Date: 2015-08-10 Impact factor: 4.162